In addition, the downregulation of SPN also induces an increase in the stemness properties of the cells, such as the expression of some cancer stem cell markers (NANOG, OCT4, SOX2, and KLF4) and enrichment in CD44+/CD24- cells, cancer-initiating cells in breast tumors with stem cell properties [93,122]. The gene discussed is KLF4; the disease is cancer.